http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101616139-B1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-0459 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-04 |
filingDate | 2009-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2016-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2016-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-101616139-B1 |
titleOfInvention | Contrast agents for applications including perfusion imaging |
abstract | The present invention is based, in part, on a method of imaging a central nervous system or cancer, comprising administering to a subject a contrast agent comprising a compound that binds to MC-1 and a visualization moiety, and scanning the subject using diagnostic imaging. ≪ / RTI > |
priorityDate | 2008-02-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 234.